Clinical Trial Update: Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of a treatment relative to standard of care in patients with COVID-19 pneumonia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Angion Biomedica Corp

Snippet

Sponsor: Angion Biomedica Corp | Conditions: COVID-19, Pneumonia | Phase 2 | Status: UNKNOWN